Embed Size (px)
Citation preview
GLOBAL INDUSTRY INSIGHT: Anti-Obesity Drugs Market Size, Share, Development, Growth, and
Demand Forecast to 2020
© P&S Market Research. All rights reserved 2
Global Anti-Obesity Drugs Market Size, Share, Development,
Growth, and Demand Forecast to 2020
The global anti-obesity drugs market is growing significantly, due to high prevalence of obesity and rich pipeline
for anti-obesity drugs. The presence of large patient pool and massive unexplored market in the emerging
economies, such as India and China, are creating ample opportunities for the growth of the global anti-obesity
drugs market. The advanced research and development facilities, and new drug developments by the key players
are propelling the demand for improved and cost-effective anti-obesity drugs, thus driving the growth of the global
anti-obesity drugs market.
Explore more or request TOC on Global Anti-Obesity Drugs Market at:
https://www.psmarketresearch.com/market-analysis/anti-obesity-drugs-market
Obesity can be defined as a medical condition, in which excessive or abnormal accumulation of fat occurs in a
patient. A person with body mass index (BMI) of 30 or above is considered obese. There are several factors
causing obesity, such as eating habits, physical inactivity, and genetic makeup. Obesity has serious negative
impact on an individual’s health. An obese individual is at a higher risk of developing chronic diseases, such as
breast cancer, endometrial cancer, colon cancer, type 2 diabetes, cardiovascular diseases, and musculoskeletal
disorders. According to the WHO, in 2014, there were 600 million obese people aged 18 years or above, which
accounted for 13% of the total adult population in the world. The prevalence of obesity is the highest in the U.S.
According to the Center for Disease Control and Prevention (CDC), in the U.S., 35.1% of the adult population
aged 20 years or above were obese during 2011 - 2012.
Some of the factors driving the growth of the global anti-obesity drugs market are increasing awareness regarding
obesity, growing healthcare expenditure, increasing geriatric population, increasing lifestyle related diseases,
growing incidences of obesity and obesity related diseases. In addition, the major players are investing huge
capital for the research and development of anti-obesity drugs; hence, fueling the growth of the global anti-obesity
drugs market. However, stringent regulatory approvals, high cost of anti-obesity prescription drugs, and
increasing patient compliance for surgical procedures are some of the factors, restraining the growth of the global
anti-obesity drugs market to some extent.
Geographically, North America leads the global anti-obesity drugs market, due to high incidences of obesity, high
healthcare expenditure, and increased awareness about obesity and obesity related risks among patients. In
addition, the increasing involvement of government and non-government organizations to educate and aware
people about the ill effects of obesity, and extensive research and development activities for the development of
anti-obesity drugs are fueling the growth of the anti-obesity drugs market in North America. Asia-Pacific is the
fastest growing region in the global anti-obesity drugs market. The fastest growth of the region is attributed to
improving healthcare infrastructure, growing healthcare expenditure and increasing geriatric population.
Moreover, the anti-obesity drugs market is growing due to increasing research and development facilities, growing
disposable income, and presence of large patient pool in the emerging countries, such as India and China.
© P&S Market Research. All rights reserved 3
Global Anti-Obesity Drugs Market Size, Share, Development,
Growth, and Demand Forecast to 2020
Browse related market research at: https://www.psmarketresearch.com/industry-report/healthcare
Some of the major players operating in the global anti-obesity drugs market are F. Hoffmann-La Roche AG, Arena
Pharmaceuticals Inc., Orexigen Therapeutics Inc., GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, Pfizer
Inc., Merck & Co. Inc., Takeda Pharmaceuticals Company Limited, Eisai Co. Ltd., Novo Nordisk A/S, Zafgen,
Rhythm Pharmaceuticals, Zydus Cadila, and Norgine B.V.
MARKET SEGMENTATION
Global Anti-Obesity Drugs Market, By Drugs Type
Peripherally Acting Anti-Obesity Drugs
Centrally Acting Anti-Obesity Drugs
Global Anti-Obesity Drugs Market, By Type
Prescription Drugs
Over-the-Counter Drugs
Global Anti-Obesity Drugs Market, By Geography
North America
Europe
Asia-Pacific
Rest of the World
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for
various geographies around the globe. We provide market research reports, industry forecasting reports,
business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate
forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through
their interaction with leading companies of the concerned domain. We help our clients with B2B market research
© P&S Market Research. All rights reserved 4
Global Anti-Obesity Drugs Market Size, Share, Development,
Growth, and Demand Forecast to 2020
and assist them in identifying various windows of opportunity, and framing informed and customized business
expansion strategies in different regions.
Contact:
Ms Somya
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
